Assessing the impact of targeted interventions on access to self‐managed abortion care in Zambia
International Journal of Gynecology & Obstetrics · 2026
DOI: 10.1002/ijgo.70775 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2026. Verfasst von Meek Mwila und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Kabwe Central Hospital, Kabwe, Zambia. Hauptthemen laut MEDLINE: Abortion, Induced, Health Services Accessibility, Self-Management. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Objective
This study evaluates the effectiveness of targeted interventions implemented in Zambia from June 2023 to May 2024 in improving access to self‐managed medical abortion (SMA) care, following the identification of barriers among providers and community through a baseline assessment and subsequent endline survey.
Methods
A pre‐ and post‐survey using quantitative method focused on barriers for healthcare providers and community, including Access and Physical Environment; Guidelines and Documents; Equipment and Supplies; Provision and Staff Training; and Financial Aspects. Interventions included improving access, provider training, commodity strengthening, and community sensitization. Participants included healthcare providers, community members, and peer educators across 30 health facilities. STATA was used for descriptive analysis and McNemar's test.
Results
Our study revealed notable improvements in the provision of SMA services across the 30 participating facilities. Facilities offering SMA services increased from 25.3% at baseline to 44% at endline, while the proportion of facilities with adequate sticks of combipacks and misoprostol increased significantly. There was also a documented rise in hospital leadership support and a reduction in charges for SMA services. Access to telemedicine services also improved, increasing from 5.3% to 20.9%. Among community health volunteers, social acceptance of SMA care increased from 54.7% to 79.3%. There was also a greater preference for home administration of SMA medication and self‐assessment of effectiveness. Facilities with trained community health volunteers delivering SMA education rose markedly from 25.3% to 93.1%.
Conclusion
The findings demonstrated significant improvements from baseline to endline, highlighting that SMA interventions were effective in improving access to safe abortion care in Zambia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Kabwe Central Hospital, Kabwe, Zambia.
- Young Emerging Scientists Zambia, Lusaka, Zambia.
- Department of Epidemiology and Biostatistics, School of Public Health, University of Zambia, Lusaka, Zambia.
- Zambia Association of Gynaecologists and Obstetricians, Lusaka, Zambia.
- Women and Newborn Hospital, University Teaching Hospitals, Lusaka, Zambia.
- Department of Policy and Management, School of Public Health, University of Zambia, Lusaka, Zambia.
ORCID-Profile: Meek Mwila
Zitieren
APA
Mwila, M., Kaonga, P., Mangala, B., Makasa, M., Macha, S., Lambwe, K., Munakampe, M. N., & Lubeya, M. K. (2026). Assessing the impact of targeted interventions on access to self‐managed abortion care in Zambia. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70775
Vancouver
Mwila M, Kaonga P, Mangala B, Makasa M, Macha S, Lambwe K, et al. Assessing the impact of targeted interventions on access to self‐managed abortion care in Zambia. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.70775
BibTeX
@article{Mwila2026,
author = {Mwila, Meek and Kaonga, Patrick and Mangala, Benedictus and Makasa, Musonda and Macha, Swebby and Lambwe, Kachali and Munakampe, Margarate Nzala and Lubeya, Mwansa Ketty},
title = {Assessing the impact of targeted interventions on access to self‐managed abortion care in Zambia},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
doi = {10.1002/ijgo.70775}
}
EUVIMED